How a pharmacy partnership improved heart failure medication adherence

Heart failure treatment often depends on a daily routine involving several medicines, changing doses, monitoring, and regular clinical review. When patients miss doses or stop treatment early, symptoms can worsen and the risk of hospitalisation can rise. For families and carers, the practical burden can be just as significant as the medical complexity.

A partnership between a local pharmacy chain, hospital clinicians, general practices, and health researchers created a more connected approach to medication use. Instead of treating dispensing as the final step, the program made community pharmacists active participants in education, follow-up, and early identification of problems.

This type of health translation reflects the work of Brisbane Diamantina Health Partners to connect research organisations, universities, and health services around practical improvements in care. The heart failure initiative shows how a familiar local service can help turn clinical evidence into a more reliable everyday treatment experience.

Why adherence falters in heart failure

People living with heart failure may take medicines that control fluid levels, blood pressure, heart rhythm, and cardiac workload. Some prescriptions require gradual dose changes, while others can cause side effects such as dizziness, fatigue, or frequent urination. Confusion can arise when medicines are started during a hospital admission and later adjusted by a general practitioner or cardiology team.

Practical barriers also affect persistence. Patients may forget doses, struggle to pay for prescriptions, have difficulty opening packaging, or misunderstand what to do when they feel better. Cognitive impairment, low health literacy, transport problems, and limited support can make a carefully designed treatment plan difficult to follow.

The partnership began with the understanding that missed doses were rarely a matter of motivation alone. Medication adherence improved when the care team identified the reason for each problem and matched it with a manageable solution.

Building a shared care pathway

Participating pharmacies used a consistent process when dispensing heart failure medicines. Pharmacists checked whether the patient understood the purpose of each medicine, asked about side effects, reviewed refill timing, and confirmed whether the current list matched the information from the patient’s doctor or hospital discharge summary.

Patients who needed additional support could receive dose administration aids, reminder systems, simplified written instructions, or a scheduled medication review. With appropriate consent, the pharmacist communicated concerns to the general practice or cardiology service. This reduced the risk that a missed refill or suspected adverse effect would remain unnoticed.

The local pharmacy chain provided reach and consistency. Patients could access support close to home, while the participating stores used shared training materials and escalation procedures. The clinical partners contributed heart failure expertise, patient safety oversight, and evaluation methods.

From dispensing to ongoing support

The most important change was the move from one-off advice to repeated contact. A pharmacist could ask about breathlessness, swelling, weight changes, and medicine tolerance during ordinary visits. These conversations did not replace medical review; they helped identify patients who required timely clinical attention.

Pharmacy staff also reinforced the action plan developed by the treating team. Patients received clear guidance about when to seek help, how to handle a missed dose, and why continuing treatment mattered even when symptoms were stable. Carers were included when the patient wanted assistance with organising medicines or recognising deterioration.

The approach supported a feedback loop. Clinicians learned which instructions were confusing, while pharmacists gained a clearer understanding of treatment goals. Researchers could then examine whether the model improved refill regularity, confidence with medicines, and continuity after discharge.

What changed for patients and services

The program’s value was measured through several indicators rather than a single outcome. Refill histories provided a practical view of whether patients obtained medicines on schedule. Medication reconciliation identified discrepancies between hospital records, primary care lists, and what patients were actually taking. Patient feedback showed whether people felt more confident managing treatment.

The improved process helped patients take medicines more consistently because it addressed specific obstacles early. Someone experiencing dizziness could receive a prompt clinical review rather than quietly discontinuing treatment. Someone missing doses because of a complex schedule could receive a clearer routine or packaging support.

For health services, better communication reduced duplicated explanations and made transitions from hospital to home safer. The partnership also created a stronger basis for identifying patients at higher risk of readmission, although medication adherence was treated as one part of broader heart failure management.

Why local relationships matter

A pharmacy is often one of the most accessible points of contact in a community. Patients may visit for prescriptions more frequently than they see a specialist, and the relationship with a familiar pharmacist can make it easier to disclose confusion, cost pressures, or unwanted effects.

Local delivery also supports equity. A centralised program may miss people who have limited transport, live alone, or find hospital-based services difficult to attend. Community pharmacies can provide practical support in neighbourhood settings, while referral pathways ensure that clinical decisions remain with appropriately qualified health professionals.

The partnership’s research and governance structure helped protect quality. Training clarified the boundaries of pharmacist-led support, privacy requirements, documentation standards, and escalation protocols. This is the same translation mindset seen in research translation work, where evidence becomes useful when it is connected to the realities of patients and frontline care.

Making the model sustainable

Sustainability depends on making the process simple enough to fit normal pharmacy and clinical workflows. A short checklist, shared referral form, and clear contact point can be more effective than a complex digital system that staff rarely use. Patients also benefit when the same language appears on discharge documents, medication labels, and written care plans.

Evaluation should continue after the initial project period. Useful measures include proportion of days covered by prescribed medicines, unplanned heart failure presentations, follow-up completion, patient understanding, and staff workload. Results should be examined across age groups, cultural backgrounds, socioeconomic circumstances, and levels of digital access.

The model can then be adapted for other chronic conditions that require sustained medicine use, including diabetes, chronic obstructive pulmonary disease, and cardiovascular disease. Its central lesson is that adherence improves when responsibility is shared across the places where care actually happens.

Practical actions for care teams

• Establish a pharmacist contact pathway for patients leaving hospital with new or changed heart failure medicines.
• Use medication reconciliation at discharge, the first community pharmacy visit, and the next primary care review.
• Ask about cost, side effects, memory, packaging, transport, and health literacy rather than assuming missed doses have one cause.
• Give patients and carers a concise written plan covering daily medicines, missed doses, warning signs, and contact details.
• Track refill patterns and patient-reported confidence, then use the findings to refine the service.

Partnerships between health services, researchers, general practices, and community pharmacies can make medication adherence a supported behaviour rather than an individual burden. By embedding follow-up in familiar local settings and connecting it to clinical expertise, the model gives patients a safer route from prescription to sustained treatment. Health organisations seeking to strengthen chronic disease care can explore collaborative opportunities, evaluation resources, and translation expertise through Brisbane Diamantina Health Partners.